Bayer’s compulsory licence appeal date set

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Bayer’s compulsory licence appeal date set

India’s Intellectual Property Appellate Board will hear Bayer’s appeal of a controversial compulsory licence ruling on August 21 in Chennai, according to Pharmabiz.com

The Controller of Patents issued a compulsory licence in March to domestic generic drug maker Natco for the cancer treatment drug sorafenib.

The German pharmaceutical company filed its appeal with the country’s Intellectual Property Appellate Board on May 4.

The compulsory licence is in force for the remaining term of the patent licence and requires Natco to pay a royalty rate of 6% of net sales of the drug.

The Controller said in March that he was granting the compulsory licence on the grounds (a) that the reasonable requirements of the public with respect to the patented invention had not been satisfied, (b) that the patented invention was not available to the public at a reasonably affordable price, and (c) that the patented invention was not being worked in India.

Bayer attacked the Patent Controller’s ruling in a statement, saying that it “damages the international patent system and endangers pharmaceutical research”.

For more of Managing IP’s coverage of the case, click here and here. More details are available on Pharmabiz.com.

more from across site and SHARED ros bottom lb

More from across our site

Law firms are rethinking litigation strategies after USPTO director John Squires said he would take control of PTAB challenges
News of Singapore planning to streamline the licensing framework for foreign law firms and a partnership between Avanci and Xprize were also among the top talking points
In major recent developments, the court also ruled on another request concerning access to documents and appointed a new panel to the Court of Appeal
A new foundation in Chile is giving women in the IP community the mentorship, and visibility they’ve long lacked
The EUIPO is keen to stress the benefits of mediation as a means of resolving IP disputes, but do roadblocks remain?
Åsa Gustafson, global patent paralegal manager at Zacco, provides insight into the world of a paralegal, explains how she keeps abreast of legal developments, and reveals a passion for weaving
Alif Gultom and Andrew Diamond of Januar Jahja & Partners explain why Indonesia must adopt reforms against bad-faith filings and safeguard its trademark system for the future
In the third episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss the ‘Women in IP’ network and the current state of diversity within the profession
Practitioners, including two ex USPTO directors, say the Patent Eligibility Restoration Act could restore clarity and predictability to US patent law, though concerns remain
News of an alliance between two Malaysian law firms and the launch of a self-help video aimed at supporting IP professionals through menopause were also among the top talking points
Gift this article